Human Rabies Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Vero Cell Rabies Vaccine, Baby Hamster Kidney (BHK), Chick Embryo Cell Rabies Vaccine, Others); Application (Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis) and Geography

Report Code: TIPRE00016878 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Human Rabies Vaccines is used to prevent rabies infection. Rabies is a kind of virus infection which spreads in human or pets by bite of rabid animals such as dog and bat. The rabies virus infects CNS and can lead to complications if not treated in time. The rabies vaccine is injected via intravenous and intramuscular route for better results.

MARKET DYNAMICS

The key market drivers for Human Rabies Vaccines Market Includes, rising cases of bite by rabid animals such as dogs. Whereas, possible side effects from rabies vaccine such as impairment of speech, high fever weakness is the restraining factor for market during the forecast period.

MARKET SCOPE

The "Human Rabies Vaccines Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Human Rabies Vaccines market with detailed market segmentation by product type and application. The Human Rabies Vaccines Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Human Rabies Vaccines Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Human Rabies Vaccines Market is segmented on the basis of product type and application. On the basis of product type the market is segmented as, vero cell rabies vaccine, chick embryo cell rabies vaccine and others. On the basis of application the market is segmented as, pre exposure prophylaxis and post exposure prophylaxs.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Human Rabies Vaccines Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Human Rabies Vaccines Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Human Rabies Vaccines Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Human Rabies Vaccines Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Human Rabies Vaccines Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Human Rabies Vaccines Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Human Rabies Vaccines market in the global market. Below mentioned is the list of few companies engaged in the Human Rabies Vaccines Market.

The report also includes the profiles of key players in Human Rabies Vaccines Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Serum Institute of India
  •   Sanofi Pasteur,Inc
  •   Novartis Vaccines and Diagnostics,Ltd
  •   Cadila Pharmaceuticals Ltd
  •   Merck and Co.Inc
  •   Glaxosmithkline Biologicals
  •   Berna Biotech Ltd
  •   Wyeth pharmaceuticals
  •   Medimmune LLC
  •   Cipla,Inc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Human Rabies Vaccines Market - By Product Type
1.3.2 Human Rabies Vaccines Market - By Application
1.3.3 Human Rabies Vaccines Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. HUMAN RABIES VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. HUMAN RABIES VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. HUMAN RABIES VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. HUMAN RABIES VACCINES - GLOBAL MARKET OVERVIEW
6.2. HUMAN RABIES VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. HUMAN RABIES VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. VERO CELL RABIES VACCINE
7.3.1. Overview
7.3.2. Vero Cell Rabies Vaccine Market Forecast and Analysis
7.4. BABY HAMSTER KIDNEY (BHK)
7.4.1. Overview
7.4.2. Baby Hamster Kidney (BHK) Market Forecast and Analysis
7.5. CHICK EMBRYO CELL RABIES VACCINE
7.5.1. Overview
7.5.2. Chick Embryo Cell Rabies Vaccine Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. HUMAN RABIES VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PRE-EXPOSURE PROPHYLAXIS
8.3.1. Overview
8.3.2. Pre-Exposure Prophylaxis Market Forecast and Analysis
8.4. POST-EXPOSURE PROPHYLAXIS
8.4.1. Overview
8.4.2. Post-Exposure Prophylaxis Market Forecast and Analysis

9. HUMAN RABIES VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Human Rabies Vaccines Market Overview
9.1.2 North America Human Rabies Vaccines Market Forecasts and Analysis
9.1.3 North America Human Rabies Vaccines Market Forecasts and Analysis - By Product Type
9.1.4 North America Human Rabies Vaccines Market Forecasts and Analysis - By Application
9.1.5 North America Human Rabies Vaccines Market Forecasts and Analysis - By Countries
9.1.5.1 United States Human Rabies Vaccines Market
9.1.5.1.1 United States Human Rabies Vaccines Market by Product Type
9.1.5.1.2 United States Human Rabies Vaccines Market by Application
9.1.5.2 Canada Human Rabies Vaccines Market
9.1.5.2.1 Canada Human Rabies Vaccines Market by Product Type
9.1.5.2.2 Canada Human Rabies Vaccines Market by Application
9.1.5.3 Mexico Human Rabies Vaccines Market
9.1.5.3.1 Mexico Human Rabies Vaccines Market by Product Type
9.1.5.3.2 Mexico Human Rabies Vaccines Market by Application
9.2. EUROPE
9.2.1 Europe Human Rabies Vaccines Market Overview
9.2.2 Europe Human Rabies Vaccines Market Forecasts and Analysis
9.2.3 Europe Human Rabies Vaccines Market Forecasts and Analysis - By Product Type
9.2.4 Europe Human Rabies Vaccines Market Forecasts and Analysis - By Application
9.2.5 Europe Human Rabies Vaccines Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Human Rabies Vaccines Market
9.2.5.1.1 Germany Human Rabies Vaccines Market by Product Type
9.2.5.1.2 Germany Human Rabies Vaccines Market by Application
9.2.5.2 France Human Rabies Vaccines Market
9.2.5.2.1 France Human Rabies Vaccines Market by Product Type
9.2.5.2.2 France Human Rabies Vaccines Market by Application
9.2.5.3 Italy Human Rabies Vaccines Market
9.2.5.3.1 Italy Human Rabies Vaccines Market by Product Type
9.2.5.3.2 Italy Human Rabies Vaccines Market by Application
9.2.5.4 Spain Human Rabies Vaccines Market
9.2.5.4.1 Spain Human Rabies Vaccines Market by Product Type
9.2.5.4.2 Spain Human Rabies Vaccines Market by Application
9.2.5.5 United Kingdom Human Rabies Vaccines Market
9.2.5.5.1 United Kingdom Human Rabies Vaccines Market by Product Type
9.2.5.5.2 United Kingdom Human Rabies Vaccines Market by Application
9.2.5.6 Rest of Europe Human Rabies Vaccines Market
9.2.5.6.1 Rest of Europe Human Rabies Vaccines Market by Product Type
9.2.5.6.2 Rest of Europe Human Rabies Vaccines Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Human Rabies Vaccines Market Overview
9.3.2 Asia-Pacific Human Rabies Vaccines Market Forecasts and Analysis
9.3.3 Asia-Pacific Human Rabies Vaccines Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Human Rabies Vaccines Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Human Rabies Vaccines Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Human Rabies Vaccines Market
9.3.5.1.1 Australia Human Rabies Vaccines Market by Product Type
9.3.5.1.2 Australia Human Rabies Vaccines Market by Application
9.3.5.2 China Human Rabies Vaccines Market
9.3.5.2.1 China Human Rabies Vaccines Market by Product Type
9.3.5.2.2 China Human Rabies Vaccines Market by Application
9.3.5.3 India Human Rabies Vaccines Market
9.3.5.3.1 India Human Rabies Vaccines Market by Product Type
9.3.5.3.2 India Human Rabies Vaccines Market by Application
9.3.5.4 Japan Human Rabies Vaccines Market
9.3.5.4.1 Japan Human Rabies Vaccines Market by Product Type
9.3.5.4.2 Japan Human Rabies Vaccines Market by Application
9.3.5.5 South Korea Human Rabies Vaccines Market
9.3.5.5.1 South Korea Human Rabies Vaccines Market by Product Type
9.3.5.5.2 South Korea Human Rabies Vaccines Market by Application
9.3.5.6 Rest of Asia-Pacific Human Rabies Vaccines Market
9.3.5.6.1 Rest of Asia-Pacific Human Rabies Vaccines Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Human Rabies Vaccines Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Human Rabies Vaccines Market Overview
9.4.2 Middle East and Africa Human Rabies Vaccines Market Forecasts and Analysis
9.4.3 Middle East and Africa Human Rabies Vaccines Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Human Rabies Vaccines Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Human Rabies Vaccines Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Human Rabies Vaccines Market
9.4.5.1.1 South Africa Human Rabies Vaccines Market by Product Type
9.4.5.1.2 South Africa Human Rabies Vaccines Market by Application
9.4.5.2 Saudi Arabia Human Rabies Vaccines Market
9.4.5.2.1 Saudi Arabia Human Rabies Vaccines Market by Product Type
9.4.5.2.2 Saudi Arabia Human Rabies Vaccines Market by Application
9.4.5.3 U.A.E Human Rabies Vaccines Market
9.4.5.3.1 U.A.E Human Rabies Vaccines Market by Product Type
9.4.5.3.2 U.A.E Human Rabies Vaccines Market by Application
9.4.5.4 Rest of Middle East and Africa Human Rabies Vaccines Market
9.4.5.4.1 Rest of Middle East and Africa Human Rabies Vaccines Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Human Rabies Vaccines Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Human Rabies Vaccines Market Overview
9.5.2 South and Central America Human Rabies Vaccines Market Forecasts and Analysis
9.5.3 South and Central America Human Rabies Vaccines Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Human Rabies Vaccines Market Forecasts and Analysis - By Application
9.5.5 South and Central America Human Rabies Vaccines Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Human Rabies Vaccines Market
9.5.5.1.1 Brazil Human Rabies Vaccines Market by Product Type
9.5.5.1.2 Brazil Human Rabies Vaccines Market by Application
9.5.5.2 Argentina Human Rabies Vaccines Market
9.5.5.2.1 Argentina Human Rabies Vaccines Market by Product Type
9.5.5.2.2 Argentina Human Rabies Vaccines Market by Application
9.5.5.3 Rest of South and Central America Human Rabies Vaccines Market
9.5.5.3.1 Rest of South and Central America Human Rabies Vaccines Market by Product Type
9.5.5.3.2 Rest of South and Central America Human Rabies Vaccines Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. HUMAN RABIES VACCINES MARKET, KEY COMPANY PROFILES
11.1. SERUM INSTITUTE OF INDIA
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANOFI PASTEUR, INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS VACCINES AND DIAGNOSTICS LTD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CADILA PHARMACEUTICALS LTD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MERCK & CO INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GLAXOSMITHKLINE BIOLOGICALS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BERNA BIOTECH LTD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. WYETH PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MEDIMMUNE LLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CIPLA,INC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Serum Institute of India
2. Sanofi Pasteur, Inc
3. Novartis Vaccines and Diagnostics Ltd
4. Cadila Pharmaceuticals Ltd
5. Merck & Co Inc
6. GlaxoSmithKline Biologicals
7. Berna Biotech Ltd
8. Wyeth pharmaceuticals
9. Medimmune LLC
10. Cipla,Inc
TIPRE00016878
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking